Trials / Completed
CompletedNCT04714749
Feasibility and Tolerance Study for the Treatment of Varicose Ulcers by Cyanoacrylate Glue (ETUVVE)
Feasibility and Tolerance Study for the Treatment of Varicose Ulcers by Cyanoacrylate Glue
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 38 (actual)
- Sponsor
- Clinique Pasteur · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Ulcers of the lower limbs are a major public health problem whose management needs to be further improved, particularly in terms of healing time, prevalence and recurrence rate. Ulcers of venous origin, or mixed arteriovenous and predominantly venous, represent the majority of leg ulcers with an estimated proportion of 70 to 80% of cases. These are painful, disabling conditions that are difficult to treat in a lasting way. This study focuses on a treatment strategy with endovascular glue. The advantage of treating ulcers with cyanoacrylate glue is the possibility of occluding the great saphenous vein over its entire length, freeing itself from neurological complications secondary to endovenous thermal techniques (laser, radiofrequency), as well as the possibility of treating by direct puncture any perforators or tributaries feeding the ulcer. This treatment strategy would improve the healing process for a lasting resolution of this pathology. This study aims to describe the feasibility and tolerance of this type of treatment in the resolution of varicose ulcers.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Endovenous treatment | Treatment of great saphenous vein (its tributaries and possible incompetent perforators feeding the ulcer) by endovascular cyanoacrylate glue |
| DEVICE | Cyanoacrylate glue | Treatment of great saphenous vein (its tributaries and possible incompetent perforators feeding the ulcer) by endovascular cyanoacrylate glue |
Timeline
- Start date
- 2021-01-21
- Primary completion
- 2024-01-30
- Completion
- 2024-01-30
- First posted
- 2021-01-19
- Last updated
- 2026-03-06
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT04714749. Inclusion in this directory is not an endorsement.